PLEASE READ THIS NOTICE CAREFULLY - IT APPLIES TO ALL PERSONS WHO VIEW THIS SITE

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.

Investors should read the Red Herring Prospectus (as defined below) and seek professional advice before taking any action. UBS Securities India Pvt. Ltd (“UBS”) does not accept any liability whatsoever direct or indirect that may arise from the use of the information contained in the Red Herring Prospectus.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the abridged prospectus (the “Abridged Prospectus”) to the red herring prospectus (“RHP”) each dated August 1, 2026 of LEAP India Limited (the “Company”) filed with the Registrar of Companies, Mumbai-I at Mumbai (“RoC”) and submitted to the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) hosted on this website in connection with the public offering of equity shares of face value of INR 1 each of the Company (the “Offer”) that UBS is associated with as one of the Book Running Lead Managers. The Abridged Prospectus has been made available on this website in electronic form solely to comply with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Abridged Prospectus. By accessing the Abridged Prospectus, you agree to follow the following terms and conditions, including any modifications to them from time to time.

The contents of the Abridged Prospectus are for your information only and you acknowledge that access to the Abridged Prospectus is intended for use by you only and you agree not to forward the Abridged Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents herein shall be copied or duplicated in any form by any means or redistributed. UBS and/or its affiliates are not soliciting any action based on any of the information contained on this website, including the Abridged Prospectus, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. Neither UBS nor any of its affiliates represents that the contents of the Abridged Prospectus are accurate or complete. The information contained in the Abridged Prospectus may not be updated since its original publication date and may not reflect the latest updates. Any forwarding, distribution or reproduction of the contents herein in whole, or in part is unauthorized. The information contained in the draft red herring prospectus dated August 29, 2025 (“DRHP”) or the RHP and Abridged Prospectus is as of the date thereof and neither UBS nor any of its affiliates are under any obligation to update the DRHP, RHP or the Abridged Prospectus to reflect circumstances arising after the date thereof.

Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. Accordingly, the Offer related information on this site is not available to all jurisdictions. The information in this section is directed at, and is, intended for distribution to, and use by, residents of India only. The Abridged Prospectus is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) UBS would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.

The securities offered in the Offer have not been and will not be registered under the United States Securities Act of 1933 (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) within the U.S. only to persons reasonably believed to be “qualified institutional buyers” in transactions exempt from or not subject to the registration requirements of the U.S. Securities Act; and (b) outside of the U.S. in offshore transactions as defined in and in compliance with Regulation S and the applicable laws of the jurisdiction where those offers and sales are made No public offering of the Equity Shares or other securities is being made in the United States.

Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the RHP, including the section titled “Risk Factors”. Any decision on whether to invest in the equity shares described in the Abridged Prospectus must be made solely on the basis of the RHP. As there may be material changes in the DRHP versus the RHP, potential investors should not rely on the DRHP.

UBS, as a Book Running Lead Manager, has taken all necessary steps to ensure that the contents of the Abridged Prospectus as appearing on this website are identical to the Abridged Prospectus filed with SEBI and the relevant regulatory authorities in India. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither UBS nor any of its affiliates accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Neither UBS nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.

Neither UBS, nor any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.

IF YOU ARE NOT PERMITTED TO VIEW MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.

Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to UBS, the Company, or any of their respective affiliates.